Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers
Status:
Completed
Trial end date:
2021-03-25
Target enrollment:
Participant gender:
Summary
This study will be a randomised, open-label, 3-period, 3-treatment, single-dose, crossover
study in healthy subjects The study will be performed at a single study centre in the United
Kingdom.